These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 7063244)

  • 1. [Total remission of prostatic cancer following treatment with Estracyt].
    Romics I
    Orv Hetil; 1982 Jan; 123(5):287-9. PubMed ID: 7063244
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of advanced carcinoma of the prostate with estramustine phosphate (estracyt)].
    Lancina Martín JA; Chantada Abal V; Lamas Meilan AC; González Martín M
    Actas Urol Esp; 1984; 8(5):399-402. PubMed ID: 6524487
    [No Abstract]   [Full Text] [Related]  

  • 3. [Stage D1 prostatic cancer benefited by a single regimen of Estracyt].
    Hata M
    Gan To Kagaku Ryoho; 1988 May; 15(5):1787-90. PubMed ID: 3369873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of advanced carcinoma of the prostate with Estracyt.
    Nagel R; Kölln CP
    Prog Clin Biol Res; 1976; 6():267-84. PubMed ID: 1023214
    [No Abstract]   [Full Text] [Related]  

  • 5. Experiences with estramustine phosphate (Estracyt, Emcyt) in prostate cancer.
    Murphy GP; Slack NH; Mittelman A
    Semin Oncol; 1983 Sep; 10(3 Suppl 3):34-42. PubMed ID: 6364365
    [No Abstract]   [Full Text] [Related]  

  • 6. [Use of Estracyt in cases of prostatic neoplasms].
    Wesolowski S; Czaplicki M; Cieślak A
    Pol Przegl Chir; 1976 Jun; 48(6A):783-9. PubMed ID: 951325
    [No Abstract]   [Full Text] [Related]  

  • 7. [Estracyt treatment in prostatic neoplasms].
    Sander S
    Tidsskr Nor Laegeforen; 1976 Jan; 96(1):27-8. PubMed ID: 1257949
    [No Abstract]   [Full Text] [Related]  

  • 8. [The phase IV studies with Estracyt in prostatic cancer].
    Ohhori T; Kubo T; Akasaka T; Funyu T; Yagihashi Y; Kudo T; Tsuchida S; Harada T; Sasaki S; Orikasa S
    Hinyokika Kiyo; 1988 Aug; 34(8):1493-502. PubMed ID: 3057833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical effects of estramustine phosphate disodium (Estracyt) on prostatic cancer].
    Nishio S; Kishimoto T; Maekawa M; Kawakita J; Hayahara N; Yuki K; Morikawa Y; Yasumoto R; Kato Y; Funai K
    Hinyokika Kiyo; 1986 Nov; 32(11):1763-70. PubMed ID: 3825823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Estracyt and radiotherapy in the treatment of prostatic cancer].
    Van Regemorter G; Germeau F
    Acta Urol Belg; 1980 Jan; 48(1):138-48. PubMed ID: 7435350
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of prostatic carcinoma with estramustine phosphate (Estracyt).
    Benson RC
    Wis Med J; 1976 Sep; 75(9):S89-90. PubMed ID: 969557
    [No Abstract]   [Full Text] [Related]  

  • 12. [Serum testosterone and acid phosphatase levels in patients with prostatic cancer treated with Estracyt].
    Németh A; Morvay J; Vécsei B
    Orv Hetil; 1981 Apr; 122(17):1017-20. PubMed ID: 7022313
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical study of estramustine phosphate (Estracyt) on prostatic cancer].
    Murase T; Mitsuya H; Honda N; Fukatu H; Aota Y; Shinoda M; Yoshida K; Sobajima T; Ohishi M; Tsumura Y
    Hinyokika Kiyo; 1989 Jan; 35(1):179-85. PubMed ID: 2729015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of hormone-resistant prostate cancer with estramustine phosphate (Estracyt)].
    Stridsklev IC; Fosså SD; Kaalhus O
    Tidsskr Nor Laegeforen; 1984 Oct; 104(28):1977-80. PubMed ID: 6388019
    [No Abstract]   [Full Text] [Related]  

  • 15. Palliative treatment with oral Estracyte in disseminated prostatic carcinoma.
    Welvaart K
    Arch Chir Neerl; 1975; 27(3):193-8. PubMed ID: 55103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Experiences with estramustinphosphate (Estracyt) in estrogen-resistant metastasizing prostatic cancer].
    Köller A; Lunglmayr G
    Wien Med Wochenschr; 1983; 133(7):179-81. PubMed ID: 6868629
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical study of estramustine phosphate disodium (Estracyt) on prostatic cancer--results of long-term therapy for 38 patients with prostatic cancer].
    Asakawa M; Wada S; Hayahara N; Yayumoto R; Kishimoto T; Maekawa M; Morikawa Y; Kawakita J; Umeda M; Horii A
    Hinyokika Kiyo; 1990 Nov; 36(11):1361-9. PubMed ID: 2288316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuous versus intermittent oral therapy with estramustine phosphate (Estracyt).
    Vahlensieck W; Wegner G
    Scand J Urol Nephrol Suppl; 1980; 55():147-9. PubMed ID: 6938018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical evaluation of the effectiveness of estracyt and radiation therapy in the treatment of stages II and III prostatic cancer].
    Matveev BP; Figurin KM; Minakova LR; Goikhberg MI; Aslamazov EG
    Urol Nefrol (Mosk); 1986; (2):51-4. PubMed ID: 3521041
    [No Abstract]   [Full Text] [Related]  

  • 20. [Predictive value of clinical, biochemical, hormonal and histologic parameters of the endocrine response in prostatic adenocarcinoma].
    Burgos FJ; Maganto E; Jiménez M; Mayayo T; Allona A; Mateos A; Escudero A; Romero-Aguirre C
    Actas Urol Esp; 1988; 12(6):500-6. PubMed ID: 3232555
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.